Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
4,549,925
-
Shares change
-
+1,027,469
-
Total reported value, excl. options
-
$27,806,219
-
Value change
-
+$6,296,678
-
Put/Call ratio
-
15.8%
-
Number of buys
-
31
-
Number of sells
-
-6
-
Price
-
$6.13
Significant Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q2 2016
47 filings reported holding ARGS - ARGOS THERAPEUTICS INC - COM as of Q2 2016.
ARGOS THERAPEUTICS INC - COM (ARGS) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,549,925 shares
.
Largest 10 shareholders include WASATCH ADVISORS INC (2,388,481 shares), VANGUARD GROUP INC (377,497 shares), BlackRock Fund Advisors (281,679 shares), WALL STREET ASSOCIATES (185,097 shares), ALTRINSIC GLOBAL ADVISORS LLC (172,505 shares), BRIDGEWAY CAPITAL MANAGEMENT INC (135,924 shares), STATE STREET CORP (120,996 shares), NORTHERN TRUST CORP (116,094 shares), SANDERS MORRIS HARRIS INC. (115,037 shares), and GEODE CAPITAL MANAGEMENT, LLC (92,713 shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.